Published: 2020-06-26

Strategies for the prevention of malaria in pregnancy in Indonesia in the COVID-19 pandemic era

Andre Prawira-Putra, Theda Lukito, Rukhsana Ahmed


Malaria is one of the oldest infectious disease that continues to affect annually more than 200 million people globally. Pregnant women are the second most vulnerable group to malaria, besides children. A pregnant woman with malaria risks detrimental harm to herself and to her child resulting in adverse pregnancy outcomes. These adverse outcomes contribute to maternal, neonatal and infant morbidity and mortality. It is essential to protect pregnant women from malaria to improve the public health burden in malaria endemic countries.


Malaria in pregnancy, Malaria prevention, COVID-19, Pandemic, Indonesia

Full Text:



WHO. World malaria report 2019. Geneva: World Health Organization; 2019. Available at: Accessed on 8 May 2020.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmunity. 2020: 102433.

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica: Atenei Parmensis. 2020;91(1):157-60.

Our World in Data. Coronavirus (Covid-19) Deaths 2020. Available at: Accessed on 7 May 2020.

Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis. 2020;20(6):652-3.

Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK: a national cohort study using the UK Obstetric Surveillance System (UKOSS). MedRxiv. 2020.

Yu N, Li W, Kang Q, Xiong Z, Wang S, Linet X, al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020.

Sitohang V, Sariwati E, Fajariyani SB, Hwang D, Kurnia B, Hapsari RK, et al. Malaria elimination in Indonesia: halfway there. Lancet Glob Health. 2018;6(6):604-6.

Swiss Medical Group. Malaria and the Sustainable Development Goals for 2030. 2018. Available at: Accessed on 06 May 2020.

Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7(1):e1000221.

Ahmed R, Poespoprodjo JR, Syafruddin D, Khairallah C, Pace C. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial. Lancet Infect Dis. 2019;19(9):973-87.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, et al. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008;46(9):1374-81.

National malaria control programme review: Republic of Indonesia. WHO Country Office Indonesia and MoH 2011. Available at: Accessed on 7 May 2020.

Hill J, Landuwulang CUR, Ansariadi, Hoyt J, Burdam FH, Bonsapia I, et al. Evaluation of the national policy of single screening and treatment for the prevention of malaria in pregnancy in two districts in Eastern Indonesia: health provider perceptions. Malar J. 2018;17(1):309.

Webster J, Ansariadi, Burdam FH, Landuwulang CUR, Bruce J, Poespoprodjo JR, et al. Evaluation of the implementation of single screening and treatment for the control of malaria in pregnancy in Eastern Indonesia: a systems effectiveness analysis. Malar J. 2018;17(1):10.

Hoyt J, Landuwulang CUR, Ansariadi, Ahmed R, Burdam FH, Bonsapia I, et al. Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women. Malar J. 2018;17(1):341.

Eradication M. Speech by Tedros Adhanom Ghebreyesus, WHO Director-General. 2019. Available at: detail/malaria-eradication. Accessed on 7 May 2020.